Drugs Policy

On reducing drug dependency, is the Minister aware that generic buprenorphine is no longer available from the manufacturer? As a result, drug treatment uses the Subutex brand, which costs £3,000 per patient per year and is becoming increasingly expensive. Will she look into that? It is proving financially difficult to support patients with opioid-substitution therapy.